Consider the case of patient WB, a 79-year-old male with recurrent diffuse large B cell lymphoma. He was referred for chimeric antigen receptor T-cell therapy (CAR-T), a recent game-changer for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results